328 related articles for article (PubMed ID: 18381463)
1. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
[TBL] [Abstract][Full Text] [Related]
2. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.
Yang H; Gu J; Lin X; Grossman HB; Ye Y; Dinney CP; Wu X
Clin Cancer Res; 2008 Apr; 14(7):2236-44. PubMed ID: 18381966
[TBL] [Abstract][Full Text] [Related]
3. Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population.
Srivastava K; Srivastava A; Mittal B
J Hum Genet; 2010 Aug; 55(8):495-9. PubMed ID: 20520619
[TBL] [Abstract][Full Text] [Related]
4. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.
Chen M; Kamat AM; Huang M; Grossman HB; Dinney CP; Lerner SP; Wu X; Gu J
Carcinogenesis; 2007 Oct; 28(10):2160-5. PubMed ID: 17728339
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis.
Zhang Z; Wang S; Wang M; Tong N; Fu G; Zhang Z
Carcinogenesis; 2008 Oct; 29(10):1973-8. PubMed ID: 18684727
[TBL] [Abstract][Full Text] [Related]
6. Exon 3 polymorphisms and haplotypes of O6-methylguanine-DNA methyltransferase and risk of bladder cancer in southern China: a case-control analysis.
Li C; Liu J; Li A; Qian L; Wang X; Wei Q; Zhou J; Zhang Z
Cancer Lett; 2005 Sep; 227(1):49-57. PubMed ID: 15885889
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
[TBL] [Abstract][Full Text] [Related]
8. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
[TBL] [Abstract][Full Text] [Related]
11. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
Landi D; Gemignani F; Naccarati A; Pardini B; Vodicka P; Vodickova L; Novotny J; Försti A; Hemminki K; Canzian F; Landi S
Carcinogenesis; 2008 Mar; 29(3):579-84. PubMed ID: 18192692
[TBL] [Abstract][Full Text] [Related]
13. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
An J; Liu Z; Hu Z; Li G; Wang LE; Sturgis EM; El-Naggar AK; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1633-8. PubMed ID: 17684138
[TBL] [Abstract][Full Text] [Related]
14. Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population.
Mittal RD; Manchanda PK; Bhat S; Bid HK
BJU Int; 2007 Apr; 99(4):933-7. PubMed ID: 17378851
[TBL] [Abstract][Full Text] [Related]
15. A functional polymorphism in RGS6 modulates the risk of bladder cancer.
Berman DM; Wang Y; Liu Z; Dong Q; Burke LA; Liotta LA; Fisher R; Wu X
Cancer Res; 2004 Sep; 64(18):6820-6. PubMed ID: 15375002
[TBL] [Abstract][Full Text] [Related]
16. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA
Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659
[TBL] [Abstract][Full Text] [Related]
17. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
Hazra A; Chanock S; Giovannucci E; Cox DG; Niu T; Fuchs C; Willett WC; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):311-9. PubMed ID: 18268114
[TBL] [Abstract][Full Text] [Related]
18. CCR2-64I is a risk factor for development of bladder cancer.
Narter KF; Agachan B; Sozen S; Cincin ZB; Isbir T
Genet Mol Res; 2010 Apr; 9(2):685-92. PubMed ID: 20449800
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.
Zhou X; Chen X; Hu L; Han S; Qiang F; Wu Y; Pan L; Shen H; Li Y; Hu Z
Gynecol Oncol; 2010 May; 117(2):287-90. PubMed ID: 20163849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
